Ledger.Open graph →
SEC Form D · filed July 10, 2009

Presidio Pharmaceuticals, Inc

Offering
$33.8M
Sold
$18.8M
Exemption
—
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (17)

Jack Obijeski · San Francisco, CADirectorOmar Haffar · San Francisco, CAExec · DirectorFelix Baker · San Francisco, CADirectorDaniel Perez · San Francisco, CADirectorLeo Redmond · San Francisco, CAExecKenneth Galbraith · San Francisco, CAExec · DirectorRodney Ferguson · San Francisco, CADirectorSrinivas Akkaraju · San Francisco, CADirectorBruce C. Long · EDINBURGH, SCOTLAND, United KingdomExec · DirectorJohn G. Barrie · EDINBURGH, SCOTLAND, United KingdomExec · DirectorGeorge W. Browning · EDINBURGH, SCOTLAND, United KingdomExecAlan W. Paterson · EDINBURGH, SCOTLAND, United KingdomDirectorEdward H. Hocknell · EDINBURGH, SCOTLAND, United KingdomDirectorDickson H. Jackson · EDINBURGH, SCOTLAND, United KingdomDirectorAngus N. Macdonald · EDINBURGH, SCOTLAND, United KingdomDirectorNigel N. Cessford · EDINBURGH, SCOTLAND, United KingdomDirectorDavid Jobes · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗